Diane Brady: Leadership Next is powered by the folks at Deloitte who, like me, are exploring the changing roles of business ...

But if a company has been paying dividends for a long time, that can give investors confidence in its ability to continue ...

But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

as well as convenient home delivery of prescription medications and other health products. *Revenue and Net Income in Billions Since 2016, Eli Lilly’s revenue grew by 60% but income grew by 91%.

The agency said that between its spinoff from Eli Lilly in 2019 and early 2020, Elanco used discounts and rebates to entice ...

The authority notes that six such products are currently being sold through websites, social media, and other informal ...

Shares in several pharmaceutical and biotechnology companies have fallen since President-elect Trump announced Thursday that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.